Detalhe da pesquisa
1.
Outcome of patients with HCC and liver dysfunction under immunotherapy: a systematic review and meta-analysis.
Hepatology;
77(4): 1139-1149, 2023 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36632997
2.
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Hepatology;
77(4): 1095-1105, 2023 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36626622
3.
Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes.
Liver Int;
2024 Apr 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38634685
4.
Validation of the Back-table Graft Arterial Anastomosis between the Splenic Artery and Superior Mesenteric Artery: Arterial Complications after a 21-year Single-center Experience of Pancreas Transplantation.
Ann Surg;
2023 Dec 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38146951
5.
Reliability of extracellular contrast versus gadoxetic acid in assessing small liver lesions using liver imaging reporting and data system v.2018 and European association for the study of the liver criteria.
Hepatology;
76(5): 1318-1328, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35349760
6.
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Gut;
71(3): 593-604, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33741640
7.
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules.
J Hepatol;
76(4): 874-882, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34856322
8.
Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression.
Clin Gastroenterol Hepatol;
20(2): 283-292.e10, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33965578
9.
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.
Liver Int;
42(8): 1891-1901, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35608939
10.
Avoiding contrast-enhanced sequences does not compromise the precision of the simplified MaRIA for the assessment of non-penetrating Crohn's disease activity.
Eur Radiol;
32(5): 3334-3345, 2022 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35031844
11.
Limited tumour progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survival.
J Hepatol;
75(5): 1154-1163, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34171433
12.
Pancreatic Insufficiency in Patients Under Sorafenib Treatment for Hepatocellular Carcinoma.
J Clin Gastroenterol;
55(3): 263-270, 2021 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32530871
13.
Missing colorectal liver metastases: the surgical challenge.
Langenbecks Arch Surg;
406(7): 2163-2175, 2021 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34590190
14.
Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials.
Liver Int;
40(10): 2476-2488, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33021346
15.
Does transient arterial-phase respiratory-motion-related artifact impact on diagnostic performance? An intra-patient comparison of extracellular gadolinium versus gadoxetic acid.
Eur Radiol;
30(12): 6694-6701, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32607632
16.
Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
Eur Radiol;
30(1): 186-194, 2020 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31372783
17.
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules.
J Hepatol;
70(5): 874-884, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30684506
18.
Corrigendum to "Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules" [J Hepatol (2019) 874-884].
J Hepatol;
74(2): 491, 2021 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33317846
19.
Reply to: "The reported 'clear cut time association between interferon-free treatment and HCC' is anything but clear cut".
J Hepatol;
72(5): 1036-1037, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31843648
20.
Reply to: "Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules - A response".
J Hepatol;
71(2): 447-448, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31182374